Latest news for Global Battery Metals (OTC:REZZF) Stock

Global Battery Metals Ltd is a Canadian exploration and development company. It is engaged in the acquisition, exploration, and development of mineral properties. The Company has one operating segment, which is mineral exploration and development. The company holds interests in North-West Leinster Lithium Property in Ireland, Lithium King Property in Utah, the Lapoile Lithium Project in Newfoundland, the Nickel-copper project in Michigan, and the Lara copper property in Peru. Geographically, it has a presence in Ireland, North America, and Peru.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ABWN

AGTK

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

AQMS

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATHX

ARTEMIS THERAPEUTICS INC by Artemis Therapeutics, Inc.

ATMS

ATYG

BGFT

BLOZF

BOIRF

BWLVF

CBRI

CCGN

CHMR

CMGHF

COCP

CORV

COTE

CSPUF

DVLY

DYLLF

ECOR

ELGX

FERL

FINCANNA CAPITAL CORP by Fincanna Capital Corp.

FNNZF

FUAPF

FVGCF

FVVSF

GGBXF

GLBS

GTBP

GURE

HEMP

HESG

HGEN

HKTTF

HUABF

HVBTF

ICABY

IPSEY

ISIG

IWSY

KINS

KRKR

LATF

LFUGF

LFUGY

MCET

MDIN

MGXMF

MIST

MLXEF

MMJJF

MOAEF

NHNKY

NIMU

NXTTF

OCANF

OGDCF

OLVRF

PARNF

PHAT

PHTCF

PHUN

PMSO

PRTR

PSIX

QBAN

QEGY

QOIL

RETC

RKAGY

RTTR

RVLT

SEED

SEEK

SFEG

SING

SNNAF

SPVNF

SUIC

TBEV

TGIFF

TLGN

TLRY

TOCA

TRPX

TWMC

UBQU

UVSE

VFRM

VGGOF

VREOF

VVCIF

WDDMF

WHITF

ICC INTL CANNABIS CORP by ICC Intl Cannabis Corp.

WLDCF

Stocks That Hit 52-Week Lows On Wednesday

GLOBAL BATTERY METALS LTD by Global Battery Metals Ltd.

Global Battery Metals Ltd

<a href="https://www.youtube.com/watch?v=f-KMvpiUAbk" title="https://www.youtube.com/watch?v=f-KMvpiUAbk">https://www.youtube.com/watch?v=f-KMvpiUAbk</a>

Federal Reserve

Fed Chair Powell Says Trump Said The Same Things Privately In His First Administration As He Did Publicly; Asked About Influence Of New DOGE Program On The Central Banks, Says Part Of The Fed's Independence Is That It Is Self-Funded; Fed Tries To Be Good Stewards Of The Public's Money

WIIM

IREN

Iris Energy shares are trading higher after Macquarie maintained an Outperform rating on the stock and raised its price target from $13.5 to $19. Additionally, the company upsized its convertible note offering to $400 milion.

Fed Chair Powell Says Feel The Same Institutional Relationships Between The Fed And The Treasury Will Continue Under New Administration; Confident Of Having The Same Type Of Relationship With Bessent As With Other Treasury Secretaries

JANX

Janux Therapeutics shares are trading higher after Scotiabank raised its price target on the stock from $42 to $62.

-NYT Dealbook Summit
<a href="https://www.youtube.com/watch?v=f-KMvpiUAbk" title="https://www.youtube.com/watch?v=f-KMvpiUAbk">https://www.youtube.com/watch?v=f-KMvpiUAbk</a>

Fed Chair Powell Independence Lets The Fed Make Decisions For All Americans, Not Any Political Party;  There Is Broad Support In Both Parties For An Independent Fed; Do Not Think There Is Risk Of Losing It; The U.S. Economy Is In Remarkably Good Shape; Feel Very Good About Where Monetary Policy Is; Do Not Think Appointment Of A "Shadow" Fed Chair Is On The Table

FutureTech II Acquisition Corp. (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTII#NASDAQ">FTII</a>), today announced that it received an expected deficiency notification letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on November 27, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. The Staff also noted that this serves as an additional basis for delisting the Company's securities from Nasdaq and since the Company is already before a Hearings Panel for its failure to comply with the Market Value of Listed Securities requirement of Nasdaq Listing Rule 5420(a)(2) (the "Market Value of Listed Shares Rule"), the Company has until December 4, 2024 to request a stay of the sustention, pending a Hearings Panel decision. In addition, the Staff noted that based on the Company disclosure that 1,564,549 shares were tendered for redemption following the special meeting on November 18, 2024, the Company no longer complies with the minimum 1,100,000 publicly held shares requirement set forth in Listing Rule 5450(b)(2)(B) (the "Publicly Held Shares Rule").

FTII

FutureTech II Acquisition Corp. Receives Notification Of Deficiency From Nasdaq

Deep-pocketed investors have adopted a bullish approach towards Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SNPS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 26 extraordinary options activities for Synopsys. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 26% bearish. Among these notable options, 5 are puts, totaling $360,135, and 21 are calls, amounting to $956,100.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $360.0 to $660.0 for Synopsys over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Synopsys stands at 242.12, with a total volume reaching 1,694.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Synopsys, situated within the strike price corridor from $360.0 to $660.0, throughout the last 30 days.
<h3>Synopsys Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733337958_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$11.6</td>
<td>$10.6</td>
<td>$11.1</td>
<td>$560.00</td>
<td>$152.0K</td>
<td align="right">248</td>
<td align="right">175</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$23.4</td>
<td>$23.3</td>
<td>$23.4</td>
<td>$580.00</td>
<td>$119.3K</td>
<td align="right">235</td>
<td align="right">86</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$27.0</td>
<td>$26.3</td>
<td>$26.77</td>
<td>$590.00</td>
<td>$98.9K</td>
<td align="right">205</td>
<td align="right">39</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$19.6</td>
<td>$18.4</td>
<td>$19.57</td>
<td>$590.00</td>
<td>$95.1K</td>
<td align="right">148</td>
<td align="right">58</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$23.7</td>
<td>$23.1</td>
<td>$23.7</td>
<td>$590.00</td>
<td>$94.8K</td>
<td align="right">12</td>
<td align="right">45</td>
</tr>
</tbody>
</table>

<h3>About Synopsys</h3>
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
In light of the recent options history for Synopsys, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Synopsys</h3>
<ul>
<li>Trading volume stands at 646,372, with SNPS's price up by 3.03%, positioned at $587.47.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About Synopsys</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $626.6666666666666.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Synopsys, maintaining a target price of $635. 
&#x2A; An analyst from Wells Fargo has revised its rating downward to Equal-Weight, adjusting the price target to $570. 
&#x2A; An analyst from Loop Capital downgraded its action to Buy with a price target of $675. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Synopsys with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

SNPS

A Closer Look at Synopsys's Options Market Dynamics

Investors with a lot of money to spend have taken a bearish stance on Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with XOM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Exxon Mobil.
This isn't normal.
The overall sentiment of these big-money traders is split between 22% bullish and 61%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $474,429, and 12 are calls, for a total amount of $969,251.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $125.0 for Exxon Mobil during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Exxon Mobil's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Exxon Mobil's significant trades, within a strike price range of $100.0 to $125.0, over the past month.
<h3>Exxon Mobil 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733337953_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$10.55</td>
<td>$10.5</td>
<td>$10.5</td>
<td>$110.00</td>
<td>$316.0K</td>
<td>392</td>
<td>301</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$1.19</td>
<td>$1.15</td>
<td>$1.17</td>
<td>$110.00</td>
<td>$171.8K</td>
<td>16.1K</td>
<td>2.2K</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.2</td>
<td>$14.1</td>
<td>$14.1</td>
<td>$105.00</td>
<td>$141.0K</td>
<td>2.2K</td>
<td>101</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$0.45</td>
<td>$0.43</td>
<td>$0.44</td>
<td>$120.00</td>
<td>$110.0K</td>
<td>24.6K</td>
<td>3.2K</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$10.6</td>
<td>$10.25</td>
<td>$10.55</td>
<td>$110.00</td>
<td>$105.5K</td>
<td>2.8K</td>
<td>120</td>
</tr>
</tbody>
</table>

<h3>About Exxon Mobil</h3>
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one of the world's largest refiners with a total global refining capacity of 4.5 million barrels of oil per day and is one of the world's largest manufacturers of commodity and specialty chemicals.
After a thorough review of the options trading surrounding Exxon Mobil, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Exxon Mobil</h3>
<ul>
<li>Trading volume stands at 7,058,725, with XOM's price down by -2.84%, positioned at $114.33.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 58 days.</li>
</ul>
<h3>What The Experts Say On Exxon Mobil</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $123.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on Exxon Mobil with a target price of $132. 
&#x2A; An analyst from RBC Capital persists with their Sector Perform rating on Exxon Mobil, maintaining a target price of $115. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Exxon Mobil with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Market Whales and Their Recent Bets on XOM Options

Deep-pocketed investors have adopted a bearish approach towards On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ONON usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for On Holding. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 30% leaning bullish and 70% bearish. Among these notable options, 2 are puts, totaling $186,154, and 8 are calls, amounting to $545,048.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $70.0 for On Holding over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for On Holding's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of On Holding's whale activity within a strike price range from $50.0 to $70.0 in the last 30 days. 
<h3>On Holding Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733337948_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$4.25</td>
<td>$4.2</td>
<td>$4.25</td>
<td>$65.00</td>
<td>$141.1K</td>
<td align="right">868</td>
<td align="right">532</td>
</tr>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$21.7</td>
<td>$20.0</td>
<td>$21.7</td>
<td>$50.00</td>
<td>$130.2K</td>
<td align="right">84</td>
<td align="right">62</td>
</tr>
<tr>
<td>ONON</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$7.7</td>
<td>$7.65</td>
<td>$7.65</td>
<td>$62.50</td>
<td>$102.5K</td>
<td align="right">88</td>
<td align="right">140</td>
</tr>
<tr>
<td>ONON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$62.50</td>
<td>$83.6K</td>
<td align="right">42</td>
<td align="right">231</td>
</tr>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$62.50</td>
<td>$75.0K</td>
<td align="right">347</td>
<td align="right">140</td>
</tr>
</tbody>
</table>

<h3>About On Holding</h3>
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa, and Asia-Pacific region.
<h3>On Holding's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,644,180, the ONON's price is down by -0.6%, now at $59.18. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 97 days.</li>
</ul>
<h3>What The Experts Say On On Holding</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $58.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Telsey Advisory Group has decided to maintain their Outperform rating on On Holding, which currently sits at a price target of $53. 
&#x2A; Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on On Holding with a target price of $60. 
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on On Holding, maintaining a target price of $62. 
&#x2A; An analyst from BTIG upgraded its action to Buy with a price target of $64. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for On Holding, targeting a price of $53. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for On Holding, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ONON

Unpacking the Latest Options Trading Trends in On Holding

Rumors

Watching The Hershey Company; Traders Circulate Unconfirmed Rumor Suggesting The Co Is In Talks To be Acquired

Wall Street extended its rally on Wednesday, driven by robust gains in technology stocks, as investor optimism around AI-fueled <a href="https://www.benzinga.com/markets">growth continued to strengthen.</a>
The Nasdaq 100 climbed 0.9%, pushing further into record territory following Tuesday&#8217;s highs. The S&amp;P 500 advanced 0.4%, hitting 6,077—a fresh record-high milestone—eyeing its twelfth gain in thirteen sessions.
Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) advanced over 2% by midday, breaking all-time highs previously set in November. The e-commerce giant&#8217;s gains were bolstered by strong early holiday sales and optimism stemming from the AWS annual conference, where AI <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42321567/amazon-hits-all-time-highs-eyes-best-2-year-rally-since-2010-cyber-season-marks-record-sales-aws-shines-with-ai-innovations">advancements took center stage.</a>
Fresh economic data offered a mixed narrative. The ISM services index showed a slower-than-expected growth in November, while ADP reported private payroll growth of 146,000 for the month, slightly under the <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42314234/private-employers-add-fewer-than-predicted-jobs-in-november-manufacturing-was-the-weakest-weve-seen-since-spring">consensus estimate of 150,000.</a>
St. Louis Federal Reserve President Alberto Musalem struck a cautious tone on monetary policy, suggesting a potential slowdown or pause in the pace of interest rate cuts <a href="https://www.benzinga.com/news/econ-s/24/12/42316647/interest-rate-cut-in-december-st-louis-feds-musalem-urges-patient-approach-in-last-mile-to-2">might soon be warranted.</a>
The dollar weakened after the ISM report, while U.S. Treasury yields erased earlier gains and remained steady by midday.
In commodities, gold added 0.3%, while natural gas and crude oil prices declined 2.6% and 1%, respectively.
Meanwhile, the cryptocurrency market struggled to keep up with the broader risk-on mood. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slipped 0.2%, trading just above $95,000
<h2 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
<td>%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,428.69</td>
<td>+199.37</td>
<td>0.9%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,073.20</td>
<td>+23.32</td>
<td>0.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,864.46</td>
<td>+158.93</td>
<td>0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,422.11</td>
<td>+5.76</td>
<td>0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:50 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120224&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.4% to $606.41.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose 0.4% to $449.79.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 1% to $521.87.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.3% to $240.68.</li>
<li>The&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, rising 1.6%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 2.4%.</li>
</ul>
<h2 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h2>
<ul>
<li>Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) rose over 7% in reaction to its quarterly results, which delivered slightly lower-than-expected earnings. </li>
<li>Other stocks reacting to earnings included Pure Storage Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) up 24%, Okta Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) up 4.8%, The Campbells Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) down 6%, Dollar Tree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) up 2.4%, and Chewy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) down 3.8%.</li>
<li>Companies slated to report their earnings after the close are Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), SentinelOne Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>), PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) and Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>). </li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42319796/tesla-analyst-lowers-q4-delivery-estimate-says-2-dynamics-will-determine-ev-stocks-valuation">Tesla Analyst Lowers Q4 Delivery Estimate, Says 2 Dynamics Will Determine EV Stock&#8217;s Valuation</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Earnings

Equities

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

AMZN

CHWY

SPDR Dow Jones Industrial Average ETF Trust

DLTR

FIVE

MRVL

OKTA

PSTG

Tech Stocks Extend Record Highs On AI Optimism, Marvell Rockets, Bitcoin Hovers Near $95,000: What's Driving Markets Wednesday?

On Wednesday, Novavax, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) agreed to sell its Bohumil,&nbsp;Czech Republic manufacturing facility to Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42308359/novavax-announces-sale-of-czech-republic-manufacturing-site-to-novo-nordisk-for-200-million" rel="noreferrer noopener">for&nbsp;$200 million</a>.
The agreement includes transferring assets, including a 150,000-square-foot recombinant protein manufacturing facility with support buildings, the existing workforce, and all related and required infrastructure.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41878334/fda-gives-green-signal-to-novavaxs-covid-19-influenza-combo-vaccine-late-stage-trial" rel="noreferrer noopener">FDA Gives Green Signal To Novavax&#8217;s COVID-19-Influenza Combo Vaccine Late-Stage Trial</a>
The agreement provides Novavax with significant, non-dilutive capital, further enabling the company to advance its corporate growth strategy and drive value from its early—and late-stage pipeline using its proven technology platform, which consists of Matrix-M adjuvant and nanoparticle protein-based technology.
In addition to the&nbsp;$190 million&nbsp;cash payment in 2024 and an additional&nbsp;$10 million&nbsp;in 2025, Novavax expects the sale of the facility to result in annual operating cost reductions of approximately&nbsp;$80 million.
&#8220;The decision to sell the&nbsp;Czech Republic&nbsp;manufacturing facility aligns with our previously announced commitment to evolve Novavax into a more lean and agile organization focused on partnering our pipeline assets and technology platform,&#8221; said&nbsp;John C. Jacobs, President and Chief Executive Officer, Novavax.
Last month, Novavax lowered its 2024 revenue guidance to $650 million—$700 million, compared to prior guidance of $700 million—$800 million and a <a target="_blank" href="https://www.benzinga.com/24/11/41904976/novavax-stock-falls-on-lower-2024-revenue-forecast-q3-earnings-beat-consensus-estimates" rel="noreferrer noopener">consensus of $761.5 million</a>.
Price Action: NVAX stock is down 2.32% at $8.215 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42319010/aramco-linde-schlumberger-form-alliance-for-one-of-the-worlds-largest-ccs-hubs" target="_blank" rel="noreferrer noopener">Aramco, Linde, Schlumberger Form Alliance For Carbon Capture And Storage Hub</a></li>
</ul>
Photo via Shutterstock

Biotech

Health Care

NVAX

Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million

President-elect Donald J. Trump on Thursday announced Paul Atkins as his nominee to lead the <a href="https://www.benzinga.com/24/12/42300549/paul-atkins-reportedly-tapped-for-sec-chair-under-trump-administration">U.S. Securities and Exchange Commission (SEC)</a>.
Known for his regulatory pragmatism and expertise in financial markets, Atkins' nomination signals a potentially transformative shift in the agency's approach to digital assets.
&#8220;Paul is a proven leader for common-sense regulations,&#8221; Trump <a href="https://truthsocial.com/@realDonaldTrump/posts/113595807734621827">stated</a> in his announcement. &#8220;He also recognizes that digital assets and other innovations are crucial to Making America Greater than Ever Before.&#8221;
This emphasis on digital innovation aligns with Atkins' previous statements, where he described Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a &#8220;revolutionary technology&#8221; that should not be stifled by excessive regulation.
Atkins, the founder and CEO of Patomak Global Partners, a risk management consultancy, brings extensive experience to the role. 
He served as an <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42221293/donald-trump-eyes-former-sec-comissioner-paul-atkins-as-gary-genslers-successor">SEC commissioner from 2002 to 2008</a> under President George W. Bush and has since been a prominent voice in conservative financial policy circles.
His tenure at the SEC included advocacy for investor protection and market transparency. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42320772/south-koreas-president-to-be-impeached-in-2024-polymarket-traders-are-unsure">South Korea&#8217;s President To Be Impeached In 2024? Polymarket Traders Are Unsure</a>
More recently, as co-chairman of the Digital Chamber's Token Alliance since 2017, Atkins has worked on issues surrounding digital assets, further demonstrating his commitment to fostering innovation in the financial sector.
Industry leaders view Atkins&#8217; nomination as a pivotal moment for the SEC, particularly after criticism of the enforcement-heavy regulatory stance under outgoing Chair Gary Gensler. 
Gensler's approach created significant uncertainty for the rapidly evolving cryptocurrency market. Atkins is expected to prioritize collaboration over punitive measures, offering a more balanced regulatory framework.
Atkins' nomination also comes amid broader changes in Trump's administration.
He is reportedly on good terms with Scott Bessent, the president-elect&#8217;s pick for Treasury Secretary, which could lead to coordinated financial policy initiatives. 
His appointment is seen as a move toward fostering innovation while <a href="https://www.benzinga.com/24/12/42300549/paul-atkins-reportedly-tapped-for-sec-chair-under-trump-administration">maintaining investor protections.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42317460/vladimir-putin-says-nobody-can-ban-bitcoin-stresses-crypto-will-develop-one-way-or-the-other">Vladimir Putin Says &#8216;Nobody Can Ban Bitcoin,&#8217; Stresses Crypto Will Develop &#8216;One Way Or The Other&#8217;</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Trump Nominates Paul Atkins As SEC Chair, Emphasizing Digital Assets As Key To 'Making America Greater'

The Benzinga Future of Digital Assets conference recently provided industry leaders with a platform to discuss Bitcoin's evolving role in investment portfolios. A panel moderated by angel investor Erik LaPaglia explored how Bitcoin is transitioning from a speculative asset to a mainstay in institutional and retail investment strategies.
<h1 class="wp-block-heading">Increasing Allocations to Bitcoin</h1>
Zach Pandl, managing director of research at Grayscale Investments, highlighted the gradual adoption of Bitcoin in portfolios. 
"Bitcoin used to be 0%&#8230; now it's starting to crack into kind of 1%-2% for people," he said, referencing its growing inclusion among investors. Pandl further predicted that allocations could eventually normalize at around 5%, driven by macroeconomic factors such as inflation and government debt.
Paul Cappelli, head of ETF strategies at Galaxy Digital, added that Bitcoin has become a reliable tool for portfolio diversification.
 "It's got a pretty long track record as a diversifier now in a portfolio," he noted, citing its use as an inflation hedge and appeal to high-net-worth and institutional clients. Some investors, Cappelli explained, have even allocated as much as 10% of their portfolios to Bitcoin, reflecting its increasing legitimacy in financial markets.
<h1 class="wp-block-heading">Dominance in the Digital Asset Market</h1>
The discussion also addressed Bitcoin's current dominance in the crypto space. Robert Mitchnick, head of digital assets at BlackRock, emphasized the asset's unique standing compared to other cryptocurrencies. 
"Bitcoin&#8230; has just a total step-change different level of resonance with a lot of our investor base," he said, noting that its status as a "digital gold" differentiates it from other crypto assets.
Mitchnick pointed out that while other projects within the cryptocurrency market hold promise, Bitcoin remains in its own category. This distinction, he argued, is partly why Bitcoin has maintained its dominance and continues to attract institutional capital.
<h1 class="wp-block-heading">The Impact of Disruptive Events</h1>
The panelists also discussed how geopolitical instability and fiscal crises could drive further adoption of Bitcoin. Mitchnick outlined scenarios where Bitcoin could outperform traditional markets during economic disruption. 
&#8220;Events like geopolitical destabilization or another surge in inflation could shift the conversation from ‘is this too risky?' to ‘is it risky not to own any?'" he explained.
Pandl echoed this sentiment, stating Bitcoin's appeal lies in its ability to hedge against traditional market risks. &#8220;People just need to look around at the world and see what is going on,&#8221; he said, referencing rising debt levels and fiscal challenges as key factors driving interest in Bitcoin.
<h1 class="wp-block-heading">Looking Ahead</h1>
As Bitcoin continues its journey toward mainstream adoption, its role in diversified portfolios is becoming increasingly prominent. The panelists agreed that education, regulatory clarity and focusing on its long-term value proposition will be critical in sustaining this momentum.
Cappelli summarized the sentiment, saying, "We're living now in a world where Bitcoin is becoming part of every portfolio. There's an excellent case for why you should be holding it."
Photo: Pexels

Events

Exclusives

Interview

From 0% to 5%: How Bitcoin Secures Its Spot In Investment Strategies

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday.
The Dow traded up 0.30% to 44,838.93 while the NASDAQ rose 0.80% to 19,637.25. The S&amp;P 500 also rose, gaining, 0.23% to 6,063.99.
Check This Out: <a href="https://www.benzinga.com/24/12/42287319/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields</a>
Leading and Lagging Sectors Information technology shares jumped by 1.1% on Wednesday.
In trading on Wednesday, energy shares fell by 1.9%.
Top Headline
The ISM services PMI fell to 52.1 in November compared to 56 in October and down from market estimates of 55.5.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Cross Country Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) shares shot up 62% to $18.14 after Aya Healthcare announced a definitive agreement to acquire the company for approximately $615 million.</li>
<li>Shares of CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) got a boost, surging 102% to $0.6384 after the company announced it has been granted a 180-day extension by Nasdaq to regain compliance with its $1.00 minimum bid price requirement.</li>
<li>SRM Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares were also up, gaining 89% to $1.19 after the company announced its online sales on Amazon grew 417% since September.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Relmada Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) shares dropped 77% to $0.6438 after the company announced its Reliance II Phase 3 study indicated results were futile and unlikely to meet the primary efficacy endpoint with statistical significance.</li>
<li>Shares of Torrid Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) were down 31% to $3.18 after the company reported worse-then-expected third-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>PSQ Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) was down, falling 36% to $4.9005 after the company announced a $36.2 million registered direct offering of common stock.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $69.88 while gold traded up 0.2% at $2,673.60.
Silver traded up 0.9% to $31.780 on Wednesday, while copper rose 0.1% to $4.2045.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.32%, Germany's DAX climbed 0.96% and France's CAC 40 rose 0.53%. Spain's IBEX 35 Index rose 0.76%, while London's FTSE 100 fell 0.27%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 0.07%, Hong Kong's Hang Seng Index falling 0.02%, China's Shanghai Composite Index falling 0.42% and India's BSE Sensex gaining 0.14%.
Economics
<ul>
<li>U.S. private businesses added 146K workers to their payrolls for the month of November compared to a revised 184K gain in October, and versus market estimates of 150K.</li>
<li>The S&amp;P Global services PMI was revised downward to 56.1 in November versus a preliminary reading of 57, and compared to October's reading of 55.</li>
<li>U.S. factory orders rose by 0.2% from the previous month to $586.7 billion in October.</li>
<li>The ISM services PMI fell to 52.1 in November compared to 56 in October and down from market estimates of 55.5.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/24/12/42313903/top-3-tech-and-telecom-stocks-that-may-implode-this-quarter">Top 3 Tech And Telecom Stocks That May Implode This Quarter</a></li>
</ul>

Eurozone

Commodities

CCRN

CNEY

CURV

PSQH

RLMD

Nasdaq Surges 150 Points; ISM Services PMI Falls In November

Decibel Cannabis (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DBCCF#OTC">DBCCF</a>) is poised for significant growth, as outlined in a recent report by Zuanic &amp; Associates, which highlights Decibel&#8217;s robust cash flow generation as a key strength. 
With a projected free cash flow (FCF) of $20 million for 2025, the company boasts a significant FCF yield of 54%.&nbsp;
"With a leading franchise in Canadian pre-rolls (the category is as big as Flower in Canada rec now)&#8230;we believe Decibel should trade more in line with the larger market cap LP stocks (especially with debt leverage projected below 1.4x for next year)," senior analyst <a href="https://www.benzinga.com/topic/pablo-zuanic">Pablo Zuanic</a> wrote in the report.&nbsp;
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Market Trends, Decibel's Performance</h3>
The <a href="https://www.benzinga.com/topic/canada-cannabis">Canadian recreational cannabis market</a> saw an improvement in October and November, with a year-over-year increase of 6.7%. However, Decibel continued to experience significant <a href="https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53">sales declines</a>, dropping by 23% year-over-year.
While other major players like Tilray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) and Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) also experienced sales declines, companies like Auxly (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) and Cannara (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LOVFF#OTC">LOVFF</a>) showed substantial growth.
In terms of market share, Tilray maintained the top position, followed by Organigram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) and Village Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>). Decibel held a 4.7% market share in November.
<ul>
<li>Pre-rolls: Decibel&#8217;s core-infused<a href="https://www.benzinga.com/topic/pre-rolls"> pre-roll segment</a>, while still a significant contributor to revenue, has seen a decline in market share. "Over 97% of Decibel pre-roll sales come from the infused segment (3Q24), where Decibel has seen share erosion; after peaking at 57% in 2Q23, this was 35% in 3Q24 (1Q24 48%; 2Q24 41%)," reads <a href="https://zuanicgroup.com/">Zuanic's report</a>.&nbsp;</li>
</ul>
<ul>
<li>Vapes: Decibel&#8217;s total <a href="https://www.benzinga.com/topic/vapes">vape share</a> fell to 9.7% in 3Q24 from 11.8% in 3Q23, although the company has adapted well to the growing AIO segment. "Decibel has adapted well in AIOs now 29% of its vape sales and is #3 in the AIO segment with a 13% share," Zuanic noted.&nbsp;</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance">Decibel Acquires AgMedica, Announces Private Placement And Third Quarter Guidance</a>
<h3 class="wp-block-heading">Strategic Acquisition</h3>
The <a href="https://www.benzinga.com/news/financing/24/11/42164794/decibel-cannabis-raises-1-18m-secures-capital-for-agmedica-bioscience-integration">acquisition of AgMedica is a strategic move</a> that will significantly enhance Decibel&#8217;s market position and growth prospects. By expanding its product portfolio, distribution network, and market share, Decibel aims to capitalize on the growing Canadian cannabis market. Key benefits include:
<ul>
<li>Expanded Product Range: AgMedica brings a diverse range of products, including flowers, pre-rolls, edibles, and concentrates.</li>
<li>Enhanced Distribution Network: The acquisition will expand Decibel&#8217;s reach, allowing it to tap into new markets and customer segments.</li>
<li>Strengthened Market Position: By combining the strengths of both companies, Decibel aims to solidify its position as a leading player in the Canadian cannabis market.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/12/42297466/decibel-receives-final-tsx-venture-exchange-acceptance-for-agmedica-acquisition-and-debenture-conversion">Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion</a>
<h3 class="wp-block-heading">Zuanic's Thesis </h3>
For Zuanic, Decibel offers a compelling investment opportunity due to its financial position and growth prospects. With a projected FCF of $20 million for 2025, the stock offers a significant FCF yield of 54%.&nbsp;
Additionally, its low valuation multiples of 0.5x sales and 2.8x EBITDA make it an attractive investment. "Although we do not set price targets, at 1-2x our CY26 sales estimates, the stock could be 6-10x higher by Dec'25 vs. current levels," Zuanic concluded.&nbsp;
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41599546/canadas-cannabis-market-goes-cold-pot-prices-hit-bottom-why-top-producers-are-losin">Canada&#8217;s Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground</a>

Analyst Color

Cannabis

Market Summary

Penny Stocks

Guidance

Small Cap Analysis

Financing

Retail Sales

Small Cap

Analyst Ratings

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

DBCCF

LOVFF

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Financial giants have made a conspicuous bearish move on Chewy. Our analysis of options history for Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) revealed 12 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $385,600, and 6 were calls, valued at $532,776.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $17.5 to $35.0 for Chewy over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Chewy stands at 1727.2, with a total volume reaching 7,063.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Chewy, situated within the strike price corridor from $17.5 to $35.0, throughout the last 30 days.
<h3>Chewy 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733337105_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$4.35</td>
<td>$4.25</td>
<td>$4.25</td>
<td>$30.00</td>
<td>$206.1K</td>
<td>600</td>
<td>1.0K</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.7</td>
<td>$13.7</td>
<td>$13.7</td>
<td>$20.00</td>
<td>$146.7K</td>
<td>1.7K</td>
<td>108</td>
</tr>
<tr>
<td>CHWY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.96</td>
<td>$1.92</td>
<td>$1.92</td>
<td>$27.50</td>
<td>$140.6K</td>
<td>3.0K</td>
<td>785</td>
</tr>
<tr>
<td>CHWY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$1.16</td>
<td>$1.13</td>
<td>$1.16</td>
<td>$32.00</td>
<td>$90.8K</td>
<td>1.6K</td>
<td>897</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$35.00</td>
<td>$70.5K</td>
<td>2.7K</td>
<td>1.3K</td>
</tr>
</tbody>
</table>

<h3>About Chewy</h3>
Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Following our analysis of the options activities associated with Chewy, we pivot to a closer look at the company's own performance.
<h3>Current Position of Chewy</h3>
<ul>
<li>With a trading volume of 11,037,218, the price of CHWY is down by -3.1%, reaching $32.58.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 0 days from now.</li>
</ul>
<h3>Expert Opinions on Chewy</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $36.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Deutsche Bank continues to hold a Hold rating for Chewy, targeting a price of $28. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Chewy, maintaining a target price of $40. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Chewy, which currently sits at a price target of $36. 
&#x2A; Maintaining their stance, an analyst from Baird continues to hold a Outperform rating for Chewy, targeting a price of $40. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Chewy, targeting a price of $40. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Chewy, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Behind the Scenes of Chewy's Latest Options Trends

Comments

Global Battery Metals

News

Latest news for Global Battery Metals (OTC:REZZF) Stock

Wednesday, December 18, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga